You are here:
Biological Characterization of a New Type III Secretion System Effector from a Clinical Isolate of Aeromonas Hydrophila - Part II
Citation:
Sierra, J. C., G. Suarez, J. Sha, S. M. Foltz, V. L. Popov, C. L. Galindo, H. R. Garner, AND A. K. Chopra. Biological Characterization of a New Type III Secretion System Effector from a Clinical Isolate of Aeromonas Hydrophila - Part II. Microbial Pathogenesis. Elsevier BV, AMSTERDAM, Netherlands, 43(4):147-160, (2007).
Impact/Purpose:
Explore and support the best approaches for determining how, when, and for what pathogens, VFAR concepts can be used to identify pathogens that are hazardous to humans, in order to identify pathogens to nominate for the CCL process.
Description:
Journal article published under Cooperative Agreement with the University of Texas
Record Details:
Record Type:DOCUMENT( JOURNAL/ PEER REVIEWED JOURNAL)
Product Published Date:10/01/2007
Record Last Revised:09/12/2013
OMB Category:Other
Record ID:
190724